📰 Process Solutions News
Page 47 - Process Solutions News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Process Solutions. Real-time updates on events, politics, business and more.
June 29, 2022
/PRNewswire/ -- Caldera, part of Dover (NYSE: DOV), recently announced an agreement with Barbieri under which Caldera will serve as the master distributor for...
June 29, 2022
/PRNewswire/ -- Caldera, part of Dover (NYSE: DOV), recently announced an agreement with Barbieri under which Caldera will serve as the master distributor for...
June 24, 2022
CAPROCK Group Inc. grew its stake in shares of Baker Hughes (NYSE:BKR – Get Rating) by 42.1% in the first quarter, HoldingsChannel.com reports. The firm owned 21,640 shares of the company’s stock after purchasing an additional 6,416 shares during the period. CAPROCK Group Inc.’s holdings in Baker Hughes were worth $788,000 as of its most […]
June 22, 2022
/PRNewswire/ -- Hillphoenix, part of Dover Food Retail and Dover (NYSE: DOV) and a pioneer in designing environmentally sustainable refrigeration systems,...
June 22, 2022
/PRNewswire/ -- Hillphoenix, part of Dover Food Retail and Dover (NYSE: DOV) and a pioneer in designing environmentally sustainable refrigeration systems,...
June 18, 2022
GuruFocus Article or News written by PRNewswire and the topic is about:
June 15, 2022
/PRNewswire/ – LIQAL, part of Dover Fueling Solutions ("DFS") and Dover (NYSE: DOV), recently announced that it is expanding its liquefied natural gas (LNG)...
June 8, 2022
Vancouver, British Columbia--(Newsfile Corp. - June 8, 2022) - Foremost Lithium Resource & Technology Ltd. (CSE: FAT) (OTCQB: FRRSF) (FSE: F0R0) (WKN: A3DCC8) (www.foremostlithium.com) ("Foremost Lithium
June 8, 2022
/PRNewswire/ -- CPC (Colder Products Company), part of Dover (NYSE: DOV) and a leading manufacturer of connection technologies used in biopharmaceutical...
June 8, 2022
/PRNewswire/ -- CPC (Colder Products Company), part of Dover (NYSE: DOV) and a leading manufacturer of connection technologies used in biopharmaceutical...